Overview
Explore the groundbreaking potential of immunotherapy as a revolutionary cancer treatment in this 1-hour 2-minute conference talk from the Milken Institute. Delve into the promising shift from traditional chemotherapy to harnessing the body's natural immune system to combat cancer cells with precision. Learn how researchers are teaching immune cells to recognize and target malignant cells, potentially offering a more effective and less harmful alternative to conventional treatments. Discover the growing interest from pharmaceutical companies and investors in this cutting-edge approach. Gain insights into the oncology community's efforts to optimize immunotherapy methods, the challenges faced in research and development, and the potential impact on cancer treatment paradigms. Examine topics such as the evolution of cancer treatment, the role of the FDA and National Cancer Institute, the historical perception of immunotherapy in cancer treatment, and innovative approaches like T-cell therapy. Understand the complexities of testing combination therapies and the importance of thinking outside the box in the quest for a cancer cure.
Syllabus
Introduction
Revolution of Hope
What have we learned
The end of chemotherapy
The courage of letting research take place
Signal over noise
How many lung cancer patients
Disruptive technology
Tom Frei era
FDA response
National Cancer Institute
Why is the government so disconnected
immunotherapy had a bad name in cancer
Why the disconnect
What should happen
Testing combinations
Thinking outside the box
Tcell core therapy
Taught by
Milken Institute